| P50 | author | Sook Whan Sung | Q89087437 |
| P2093 | author name string | Jae Ho Byun | |
| | Jae Kil Park | |
| | Ji Hyung Hong | |
| | Jin Hyoung Kang | |
| | Sung-Suk Suh | |
| | Sukchan Lee | |
| | Kang San Roh | |
| P2860 | cites work | TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation status. | Q37667596 |
| | KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer | Q39205104 |
| | miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44. | Q39211497 |
| | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 |
| | Effect of c-Met inhibitor SU11274 on hepatocellular carcinoma cell growth | Q39542386 |
| | MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells | Q39546216 |
| | Knockdown of c-Met inhibits cell proliferation and invasion and increases chemosensitivity to doxorubicin in human multiple myeloma U266 cells in vitro | Q39563744 |
| | Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer | Q39592978 |
| | Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest | Q39992760 |
| | Molecular mechanism of adaphostin-mediated G1 arrest in prostate cancer (PC-3) cells: signaling events mediated by hepatocyte growth factor receptor, c-Met, and p38 MAPK pathways | Q40234882 |
| | Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. | Q40453775 |
| | Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence. | Q42256566 |
| | Prognostic impact of vascular and lymphovascular invasion in early lung cancer. | Q44644010 |
| | Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer | Q45159574 |
| | Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma | Q45333355 |
| | Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression. | Q50658268 |
| | Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. | Q53259995 |
| | miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. | Q53306726 |
| | MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells | Q21134916 |
| | The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 |
| | miR-34a repression of SIRT1 regulates apoptosis | Q24652720 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Oncomirs - microRNAs with a role in cancer | Q27860773 |
| | MicroRNA signatures in human cancers | Q27860962 |
| | Regulation of apoptosis by alternative pre-mRNA splicing | Q28259246 |
| | The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 |
| | Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 | Q28285980 |
| | Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 |
| | Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer | Q28291502 |
| | A microRNA component of the p53 tumour suppressor network | Q28305330 |
| | Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells | Q28476781 |
| | Cancer statistics, 2009 | Q29547625 |
| | microRNA-34a is tumor suppressive in brain tumors and glioma stem cells | Q30428366 |
| | MicroRNAs in cancer | Q30437444 |
| | Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607. | Q31062741 |
| | miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner | Q33901567 |
| | HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop | Q33906033 |
| | Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis | Q34108117 |
| | Small RNA combination therapy for lung cancer | Q34120092 |
| | Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway | Q34500778 |
| | HGF and c-Met interaction promotes migration in human chondrosarcoma cells | Q34548365 |
| | Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET | Q34674537 |
| | Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline | Q34705240 |
| | Prognostic factors in non-small cell lung cancer: a decade of progress | Q34844271 |
| | Elevated expression of CDK4 in lung cancer | Q34980269 |
| | Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer | Q35171541 |
| | MicroRNA expression differentiates histology and predicts survival of lung cancer | Q35184912 |
| | MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer | Q35907409 |
| | Small RNAs: classification, biogenesis, and function. | Q36063097 |
| | miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. | Q36368456 |
| P433 | issue | 12 | |
| P921 | main subject | microRNA | Q310899 |
| | adenocarcinoma | Q356033 |
| P304 | page(s) | 9327-9337 | |
| P577 | publication date | 2015-06-25 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients | |
| P478 | volume | 36 | |